- Home
- PNTG vs NEO Comparison
PNTG vs NEO Comparison
Compare PNTG & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PNTG | NEO |
|---|---|---|
| Founded | 2019 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2019 | 2008 |
Fundamental Metrics
Financial Performance| Metric | PNTG | NEO |
|---|---|---|
| Price | $30.70 | $8.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $37.00 | $11.14 |
| AVG Volume (30 Days) | 212.4K | ★ 1.4M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $947,705,000.00 | N/A |
| Revenue This Year | $24.72 | $10.63 |
| Revenue Next Year | $7.61 | $9.73 |
| P/E Ratio | $36.45 | ★ N/A |
| Revenue Growth | ★ 36.31 | N/A |
| 52 Week Low | $21.74 | $4.72 |
| 52 Week High | $35.25 | $13.74 |
Technical Indicators
Market Signals| Indicator | PNTG | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 46.79 | 49.98 |
| Support Level | $28.78 | $7.33 |
| Resistance Level | $31.94 | $8.89 |
| Average True Range (ATR) | 1.00 | 0.44 |
| MACD | 0.05 | 0.16 |
| Stochastic Oscillator | 60.37 | 79.74 |
Price Performance
Historical ComparisonAbout PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.